CLINICAL_TRIALS
trial_result
· 2022-08-23
Clinical Trial Update: Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis [Phase 2]
Summary
Phase 2 trial update of CD 2027 spray evaluated for efficacy and safety in plaque-type psoriasis; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-23